Verve Gets FDA Go-Ahead for First In-Human Base Editing Study i…
0
23
AnaptysBio Touts Positive Top-Line Phase III Data for Pustular …
0
6
Amicus Gets FDA Approval for Rare Muscle Disorder Treatment
0
6
Appili Gets FDA Approval for Liquid, Oral Reformulation of Anti…
0
2
Gilead’s Magrolimab Again Placed on Partial Clinical Hold by FDA
0
13
Chimerix’s Drug Candidate Improves Brain Tumor Survival Rate
0
15
HIV and Increased Risk for Heart Attack
0
8
NIAID funds Post-Treatment Lyme Disease Syndrome research
0
24
Taking Statins to Reduce Cardiovascular Disease in T2 Diabetics
0
31
Endocarditis in Intravenous Drug Users: A Dangerous Infection
0
18